145 related articles for article (PubMed ID: 18294840)
1. Microarray analysis of Ewing's sarcoma family of tumours reveals characteristic gene expression signatures associated with metastasis and resistance to chemotherapy.
Schaefer KL; Eisenacher M; Braun Y; Brachwitz K; Wai DH; Dirksen U; Lanvers-Kaminsky C; Juergens H; Herrero D; Stegmaier S; Koscielniak E; Eggert A; Nathrath M; Gosheger G; Schneider DT; Bury C; Diallo-Danebrock R; Ottaviano L; Gabbert HE; Poremba C
Eur J Cancer; 2008 Mar; 44(5):699-709. PubMed ID: 18294840
[TBL] [Abstract][Full Text] [Related]
2. GSTM4 is a microsatellite-containing EWS/FLI target involved in Ewing's sarcoma oncogenesis and therapeutic resistance.
Luo W; Gangwal K; Sankar S; Boucher KM; Thomas D; Lessnick SL
Oncogene; 2009 Nov; 28(46):4126-32. PubMed ID: 19718047
[TBL] [Abstract][Full Text] [Related]
3. Overcoming resistance to conventional drugs in Ewing sarcoma and identification of molecular predictors of outcome.
Scotlandi K; Remondini D; Castellani G; Manara MC; Nardi F; Cantiani L; Francesconi M; Mercuri M; Caccuri AM; Serra M; Knuutila S; Picci P
J Clin Oncol; 2009 May; 27(13):2209-16. PubMed ID: 19307502
[TBL] [Abstract][Full Text] [Related]
4. Favorable outcome of Ewing sarcoma family tumors to multiagent intensive preoperative chemotherapy: a single institution experience.
Moschovi M; Trimis G; Stefanaki K; Anastasopoulos J; Syriopoulou V; Koultouki E; Tzortzatou-Stathopoulou F
J Surg Oncol; 2005 Mar; 89(4):239-43. PubMed ID: 15726621
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors in non-metastatic Ewing's sarcoma tumor of bone: an analysis of 579 patients treated at a single institution with adjuvant or neoadjuvant chemotherapy between 1972 and 1998.
Bacci G; Longhi A; Ferrari S; Mercuri M; Versari M; Bertoni F
Acta Oncol; 2006; 45(4):469-75. PubMed ID: 16760184
[TBL] [Abstract][Full Text] [Related]
6. Current treatment for Ewing's sarcoma.
Thacker MM; Temple HT; Scully SP
Expert Rev Anticancer Ther; 2005 Apr; 5(2):319-31. PubMed ID: 15877528
[TBL] [Abstract][Full Text] [Related]
7. Array CGH and gene-expression profiling reveals distinct genomic instability patterns associated with DNA repair and cell-cycle checkpoint pathways in Ewing's sarcoma.
Ferreira BI; Alonso J; Carrillo J; Acquadro F; Largo C; Suela J; Teixeira MR; Cerveira N; Molares A; Goméz-López G; Pestaña A; Sastre A; Garcia-Miguel P; Cigudosa JC
Oncogene; 2008 Mar; 27(14):2084-90. PubMed ID: 17952124
[TBL] [Abstract][Full Text] [Related]
8. Response to melphalan in up-front investigational window therapy for patients with metastatic Ewing's family tumours.
Luksch R; Grignani G; Fagioli F; Brach del Prever A; Podda M; Aliberti S; Casanova M; Prete A; Hanau G; Tamburini A; Allione P; Tienghi A; Ferrari S; Collini P; Marchianò A; Gandola L; Aglietta M; Madon E; Picci P; Fossati-Bellani F
Eur J Cancer; 2007 Mar; 43(5):885-90. PubMed ID: 17254770
[TBL] [Abstract][Full Text] [Related]
9. DAX1, a direct target of EWS/FLI1 oncoprotein, is a principal regulator of cell-cycle progression in Ewing's tumor cells.
García-Aragoncillo E; Carrillo J; Lalli E; Agra N; Gómez-López G; Pestaña A; Alonso J
Oncogene; 2008 Oct; 27(46):6034-43. PubMed ID: 18591936
[TBL] [Abstract][Full Text] [Related]
10. Molecular abnormalities in Ewing's sarcoma.
Burchill SA
Expert Rev Anticancer Ther; 2008 Oct; 8(10):1675-87. PubMed ID: 18925858
[TBL] [Abstract][Full Text] [Related]
11. How to treat the Ewing's family of sarcomas in adult patients.
Scurr M; Judson I
Oncologist; 2006 Jan; 11(1):65-72. PubMed ID: 16401715
[TBL] [Abstract][Full Text] [Related]
12. Local and distant control in non-metastatic pelvic Ewing's sarcoma patients.
Donati D; Yin J; Di Bella C; Colangeli M; Bacci G; Ferrari S; Bertoni F; Barbieri E; Mercuri M
J Surg Oncol; 2007 Jul; 96(1):19-25. PubMed ID: 17345611
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related acute myeloid leukemia with 11q23 abnormality coexisting with refractory metastatic Ewing sarcoma: report of a case and review of the literature.
Worcester HD; Vasef MA
Pediatr Dev Pathol; 2010; 13(1):50-4. PubMed ID: 19925255
[TBL] [Abstract][Full Text] [Related]
14. Ewing's sarcoma family of tumors: an overview from diagnosis to survivorship.
Lahl M; Fisher VL; Laschinger K
Clin J Oncol Nurs; 2008 Feb; 12(1):89-97. PubMed ID: 18258578
[TBL] [Abstract][Full Text] [Related]
15. [Update on pediatric oncology].
Kalifa C; Grill J; Hartmann O
Bull Cancer; 1998 Jan; 85(1):57-8. PubMed ID: 9752350
[No Abstract] [Full Text] [Related]
16. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients.
Paulussen M; Craft AW; Lewis I; Hackshaw A; Douglas C; Dunst J; Schuck A; Winkelmann W; Köhler G; Poremba C; Zoubek A; Ladenstein R; van den Berg H; Hunold A; Cassoni A; Spooner D; Grimer R; Whelan J; McTiernan A; Jürgens H;
J Clin Oncol; 2008 Sep; 26(27):4385-93. PubMed ID: 18802150
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of papillomavirus binding factor in Ewing's sarcoma family of tumors conferring poor prognosis.
Yabe H; Tsukahara T; Kawaguchi S; Wada T; Sato N; Morioka H; Yabe H
Oncol Rep; 2008 Jan; 19(1):129-34. PubMed ID: 18097586
[TBL] [Abstract][Full Text] [Related]
18. [Long-term results following multidisciplinary treatment of localized Ewing's sarcoma in children and adolescents].
Ullmann C; Beck JD; Holter W; Petsch S; Dunst J; Sauer R; Grabenbauer GG
Strahlenther Onkol; 2008 Mar; 184(3):137-44. PubMed ID: 18330509
[TBL] [Abstract][Full Text] [Related]
19. Nucleophosmin as a candidate prognostic biomarker of Ewing's sarcoma revealed by proteomics.
Kikuta K; Tochigi N; Shimoda T; Yabe H; Morioka H; Toyama Y; Hosono A; Beppu Y; Kawai A; Hirohashi S; Kondo T
Clin Cancer Res; 2009 Apr; 15(8):2885-94. PubMed ID: 19351769
[TBL] [Abstract][Full Text] [Related]
20. Ewing sarcoma-family tumors that arise after treatment of primary childhood cancer.
Spunt SL; Rodriguez-Galindo C; Fuller CE; Harper J; Krasin MJ; Billups CA; Khoury JD
Cancer; 2006 Jul; 107(1):201-6. PubMed ID: 16721801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
